The ASTCT Gene Therapy Summit is an interactive meeting of representatives from academic and clinical centers, the biotechnology industry, ASTCT and additional collaborative professional societies focused on ex vivo gene therapy using hematopoietic stem cells.
The overarching goal of the Summit is to explore how the strengths of ASTCT centers and members can be leveraged to bring effective therapies safely and rapidly to patients while advancing the field of ex vivo gene therapy. Summit sessions will bring together experts from multiple disciplines to educate, discuss and exchange best practices, and to provide a platform for biotechnology industry representatives to interact with academic clinicians and researchers.
The 1.5 day summit will be held November 4-5, 2026, at the Joseph B. Martin Conference Center at Harvard Medical School in Boston, Massachusetts. The Summit is not accredited and will not offer any continuing education credit.